CHOOSING WISELY

for Parents: A Guide to Safer, Smarter Care

ABOUT

CHOOSING WISELY FOR PARENTS

Helping Parents Make Informed Healthcare Decisions

When a child is unwell, it’s only natural for parents to seek quick and effective solutions. However, not all medical treatments are beneficial—and in some cases, they may do more harm than good. That’s why the European Academy of Paediatrics (EAP) Choosing Wisely Group has developed the Choosing Wisely Parent Booklet: a clear, accessible guide to help families navigate common paediatric health concerns.

 

This short, practical booklet presents ten evidence-based recommendations, each aimed at avoiding unnecessary or potentially harmful interventions. Written in straightforward language, it explains what parents should know, what to do, and what not to do when faced with common childhood illnesses such as coughs, ear infections, reflux, and fever.

View Parent's Booklet (PDF)

🔍 What’s Inside?

The Choosing Wisely Parent Booklet includes guidance on:

  • When not to use cough medicines in children

  • Managing bronchiolitis without routine steroids or inhalers

  • Reducing overuse of antibiotics in various paediatric cases

  • Avoiding unnecessary tests for food allergies

  • Understanding when hospitalisation or prolonged treatment may not be needed

Each section is accompanied by simple checklists to help parents make safe decisions in collaboration with their healthcare providers.

🌍 Translations Available

English

Folder Containing PDF's

Access Now

French

Folder Containing PDF's

Access Now

German

Folder Containing PDF's

Access Now

Italian

Folder Containing PDF's

Access Now

Portuguese

Folder Containing PDF's

Access Now

Slovenian

Folder Containing PDF's

Access Now

Spanish

Folder Containing PDF's

Access Now
close menu icon

Your Enquiries Are Welcome

We will respond to you by Email

""
 

Core-MD Project

Coordinating Research and Evidence for Medical Devices (CORE-MD)

New ways to test high-risk medical devices.

 

Manufacturers of medical devices need to test their products before being allowed to market them. Specifically, they require clinical data showing their medical device is safe and efficient. In this context, the EU-funded CORE-MD project will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators. The project will propose how new trial designs can contribute and suggest ways to aggregate real-world data from medical device registries.


It will also conduct multidisciplinary workshops to propose a hierarchy of levels of evidence from clinical investigations, as well as educational and training objectives for all stakeholders, to build expertise in regulatory science in Europe. CORE–MD will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators, to achieve an appropriate balance between innovation, safety, and effectiveness. A unique collaboration between medical associations, regulatory agencies, notified bodies, academic institutions, patients’ groups, and health technology assessment agencies, will systematically review methodologies for the clinical investigation of high-risk medical devices, recommend how new trial designs can contribute, and advise on methods for aggregating real-world data from medical device registries with experience from clinical practice The consortium is led by the European Society of Cardiology and the European Federation of National Associations of Orthopaedics and Traumatology, and involves all 33 specialist medical associations that are members of the Biomedical Alliance in Europe.

EAP Representative:

  • BERTHOLD KOLETZKO
Read more